DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CHLOROQUINE HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Chloroquine Hydrochloride

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00074841	Trial of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine for the Treatment of Uncomplicated Malaria in India	Completed	Pfizer	Phase 2/Phase 3	This primary objective of this study is to assess whether the combination of Azithromycin with chloroquine is non-inferior to the combination of sulfadoxine-pyrimethamine plus chloroquine, when used to treat uncomplicated cases of malaria due to Plasmodium falciparum in adults in India.
NCT00082563	Azithromycin in Combination With Chloroquine Versus Chloroquine in the Eradication of Asymptomatic Plasmodium Falciparum	Terminated	Pfizer	Phase 2	The purpose of this study is to determine if Azithromycin in combination with chloroquine is superior to chloroquine alone in eradicating P. falciparum asexual parasitemia in asymptomatic, semi-immune adults in Western Kenya.
NCT00082576	Azithromycin Plus Chloroquine Versus Mefloquine for the Treatment of Uncomplicated Malaria in Africa	Completed	Pfizer	Phase 2/Phase 3	The primary objective is to confirm the hypothesis that azithromycin plus chloroquine is non-inferior to mefloquine for the treatment of symptomatic, uncomplicated malaria due to P. falciparum.
NCT00084227	Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America	Completed	Pfizer	Phase 2/Phase 3	The primary objective is to confirm the hypothesis that azithromycin plus chloroquine is non-inferior to atovaquone-proguanil for the treatment of symptomatic, uncomplicated malaria due to P. falciparum.
NCT00084240	Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine For The Treatment Of Uncomplicated, Symptomatic Falciparum Malaria In Southeast Asia	Terminated	Pfizer	Phase 2/Phase 3	The primary objective is to confirm the hypothesis that azithromycin (optimal dose once daily for three days) plus chloroquine is non-inferior to sulfadoxine-pyrimethamine plus chloroquine for the treatment of uncomplicated, symptomatic malaria due to P. falciparum.

Clinical Trial Conditions for Chloroquine Hydrochloride

Condition Name

Condition Name for Chloroquine Hydrochloride
Intervention	Trials
Malaria	62
Vivax Malaria	18
Malaria, Falciparum	13
Malaria, Vivax	12

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Chloroquine Hydrochloride
Intervention	Trials
Malaria	126
Malaria, Vivax	38
Malaria, Falciparum	36
HIV Infections	7

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Chloroquine Hydrochloride

Trials by Country

Trials by Country for Chloroquine Hydrochloride
Location	Trials
United States	39
Netherlands	15
Thailand	14
Brazil	13
Afghanistan	11

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Chloroquine Hydrochloride
Location	Trials
Maryland	7
New York	6
Missouri	4
Pennsylvania	3
Ohio	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Chloroquine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Chloroquine Hydrochloride
Clinical Trial Phase	Trials
Phase 4	43
Phase 3	39
Phase 2/Phase 3	15

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Chloroquine Hydrochloride
Clinical Trial Phase	Trials
Completed	118
Recruiting	29
Unknown status	15

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Chloroquine Hydrochloride

Sponsor Name

Sponsor Name for Chloroquine Hydrochloride
Sponsor	Trials
University of Oxford	17
London School of Hygiene and Tropical Medicine	15
Centers for Disease Control and Prevention	13

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Chloroquine Hydrochloride
Sponsor	Trials
Other	327
Industry	32
U.S. Fed	21

Export unavailable in trial.
Subscribe for complete access.